(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline | CAS:118864-75-8

We serve (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS:118864-75-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline

Chemical Name: (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline
CAS.NO:  118864-75-8
Synonyms:
(1S)-1-Phenyl-1,2,3,4-tetrahydro-isopquinoline
(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline

Molecular Formula: C15H15N
Molecular Weight:   209.28600

Physical and Chemical Properties:
Density: 1.065
Boiling point: 338ºC
Melting point: 80-82ºC
Flash point: 167ºC
Refractive index: 1.589

Specification:
Appearance: White powder
Purity:≥99.0%
Water:≤0.5%
Any single impurity :≤0.1%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
(S) -1-phenyl-1,2,3,4-tetrahydroisoquinoline (118864-75-8) is a new intermediate for the treatment of neurotype frequent urinary drugs, Sofina.Intermediates of Solifenacin succinate CAS:242478-38-2.



Contact us for information like (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline Use and application,(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline technical grade,usp/ep/jp grade.


Related News: According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.3-(Cyanomethyl)Pyridine manufacturer According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.1,5-Dichloropentane supplier Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China.benzyl (2S)-2-amino-3-methylbutanoate,hydrochloride vendor You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.